Survey of naturally occurring CD4(+) T cell responses against NY-ESO-1 in cancer patients: Correlation with antibody responses

NY-ESO-1 is one of the most immunogenic proteins described in human cancers, based on its capacity to elicit simultaneous antibody and CD8(+) T cell responses in vivo. Although HLA class II restricted epitopes from NY-ESO-1 have been identified, no broad survey has yet established the status of natu...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Gnjatic, Sacha, Atanackovic, Djordje, Jäger, Elke, Matsuo, Mitsutoshi, Selvakumar, Annamalai, Altorki, Nasser K., Maki, Robert G., Dupont, Bo, Ritter, Gerd, Chen, Yao-Tseng, Knuth, Alexander, Old, Lloyd J.
Format: Artigo
Idioma:Inglês
Publicat: National Academy of Sciences 2003
Matèries:
Biological Sciences
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC166404/
https://ncbi.nlm.nih.gov/pubmed/12853579
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.1133324100
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars